Customer Problem

StayPut will assist in the adhesion of wearable medical devices on the body, for both pediatric and adult patients. These medical devices can be both painful to insert and difficult to adhere to the skin. When a device falls off before the intended duration of use, it’s both costly and frustrating for the patient to re-administer a new one.

Our Solution

  • Utilizing StayPut will assist in solving the skin adhesion issue, while also being advantageous for parents of pediatric patients wanting to ease the stress of having to Wear the device by bringing a “fun” element to it.
  • The combination of clinical functionality, potential monetary savings, ease of use and decorative discreetness is why patients of all ages will utilize the StayPut brand.

StayPut Use & Markets

USE

Intended to be used each time a patient puts on a new wearable medical device. Most devices are designed to be worn anywhere from 3-7 consecutive days, and most devices are intended to be worn throughout the course of the patient’s lifetime. Therefore the need for a product, which makes the wearable device easier to adhere and more “socially acceptable”, is in high demand.

StayPut is easily administered by a patient or caregiver, via peeling offthe two perforated stickers on the back of the product and placing over top of the device, reinforcing the device’s existing adhesive.

StayPut is latex free, breathable, flexible with the body, waterproof and durable.

PRIMARY MARKET - DIABETES CARE

Insulin pump use in pediatric patients is highest in the United States. Our product keeps the pump attached and secure.

  • In 2008-09, the annual incidence of newly diagnosed diabetes in youth was 23,5252.
  • About 208,000 Americans, under the age of 20, are estimated to have diagnosed diabetes.
  • 1.4 million Americans are diagnosed with diabetes every year.
  • As of 2015, there were 3 million patients on intensive insulin therapy, with 600,000 of those patients wearing a CSII (insulin pump).
  • In 2012, 29.1 million Americans (or 9.3% of the population) had diabetes.
  • The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.
FUTURE MARKETS
  • Cardiovascular (Heart Monitor Adhesives)
  • Oncology (Infusion Port Adhesive)
  • Hospital Intervention (IV and PICTLine Sterile Adhesives)